Clinical Trials in Maine
Are you looking to enroll in a clinical trial in Maine? With new trials like "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" and "Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)", the Pine Tree State has established itself as a great location for clinical research studies, particularly in cities like Bangor and Portland.
While some individuals are looking for paid clinical trials, others want to help advance dermatology and toxicology clinical research in Maine. To begin your search for Maine clinical trials, use the form on the right.